TAG:
laboratory organization
Expert Says Time is Now For Labs to Adopt QMS
By Robert Michel | From the Volume XVI No. 14 – October 12, 2009 Issue
CEO SUMMARY: Laboratories in the United States are knowledgeable about the use of quality control (QC) and quality assurance (QA) programs. But QC and QA represent only two small parts of a comprehensive quality management system (QMS), says Lucia Berte, an expert in lab quality. One bene…
New Lab Company Is Launched By Geisinger Health System
By Robert Michel | From the Volume XVI No. 12 – August 31, 2009 Issue
WITH A SIMPLE ANNOUNCEMENT last month, Geisinger Health System of Danville, Pennsylvania, launched a new laboratory outreach company, called Proven Diagnostics. From a facility located in Bethlehem, Pennsylvania, Proven Diagnostics intends to compete for lab testing…
Despite the Recession, Many Local Labs Thrive
By Robert Michel | From the Volume XVI No. 7 – May 18, 2009 Issue
CEO SUMMARY: Each year, the Executive War College offers useful perspectives on the current lab testing marketplace. This year’s gathering took place as the recession deepened. Yet that didn’t dampen the optimism and energy of 60 speakers and more than 450 attendees from 12 c…
Kaiser in Colorado Uses Lab Test Data to Improve Cardiac Care
By Robert Michel | From the Volume XVI No. 6 – April 27, 2009 Issue
CEO SUMMARY: Proud of a 73% reduction in mortality among patients with coronary artery disease (CAD) at Kaiser Permanente Colorado, clinical care teams there demonstrate how integrated care and more effective use of laboratory test data can lead to remarkable improvements in pati…
Medically Unlikely Edits Are Back–and a Problem!
By Robert Michel | From the Volume XVI No. 5 – April 6, 2009 Issue
CEO SUMMARY: On January 1, 2009, CMS implemented Phase VIII of its policy on medically unlikely edits (MUEs) involving about 100 laboratory CPT Codes. It also began to deny whole claims, not just the “medically unlikely” parts of claims. After hearing of the problem in early …
Unprecedented Times Lie Ahead For Labs
By Robert Michel | From the Volume XVI No. 4 – March 16, 2009 Issue
CEO SUMMARY: Here’s a lab industry first: insight and analysis about why hospital/health system laboratories are already feeling the financial pinch as their parent organizations scramble to conserve and accumulate cash. That’s bad news for IVD vendors and other lab industry …
Inaccurate Results + Quest Dominates News Cycle
By R. Lewis Dark | From the Volume XVI No. 1 – January 12, 2009 Issue
CEO SUMMARY: Most laboratory professionals don’t know it yet, but significant changes occurred to the entire lab industry last week. After Quest Diagnostics Incorporated acknowledged that it was retesting tens of thousands of patients because 7% of the Vitamin D results it repo…
ASCP Awarded PEPFAR II Funds for Lab Assistance
By Robert Michel | From the Volume XVI No. 1 – January 12, 2009 Issue
CEO SUMMARY: With new Congressional authorization and funding of $48 billion, PEPFAR II—a second five-year initiative to help targeted countries battle HIV, AIDs, tuberculosis, and malaria—is about to get under way. To better support diagnosis and management of HIV/AIDs patie…
Vitamin D Test Issues Trigger Doctor Discussion
By Robert Michel | From the Volume XV No. 17 – December 22, 2008 Issue
CEO SUMMARY: In recent months, Quest Diagnostics Incorporated quietly launched a campaign to notify certain patients and their physicians that they had received “inaccurate results” for Vitamin D tests it had performed. This notice includes an offer to retest the patient at no charge….
First U.S. Labs Nearing ISO:15189 Accreditation
By Robert Michel | From the Volume XV No. 11 – August 18, 2008 Issue
CEO SUMMARY: Laboratories, hospitals, and other health-care providers in the United States will increasingly be required to adopt quality management systems (QMS) as part of their regular operational routine. This is consistent with trends in other developed countries. Several U.S. labora…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized